| The cold‐shock stress response in Mycobacterium smegmatis induces the expression of a histone‐like protein K Shires, L Steyn Molecular Microbiology 39 (4), 994-1009, 2001 | 61 | 2001 |
| The validation of forensic DNA extraction systems to utilize soil contaminated biological evidence M Kasu, K Shires Legal medicine 17 (4), 232-238, 2015 | 28 | 2015 |
| The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma K Wienand, K Shires PLoS One 10 (3), e0120734, 2015 | 24 | 2015 |
| Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patients K Shires, K Wienand Journal of cancer research and clinical oncology 142, 2383-2396, 2016 | 15 | 2016 |
| The role of Cancer/Testis Antigens in Multiple Myeloma pathogenesis and their application in disease monitoring and therapy K Shires, T Van Wyk Critical reviews in oncology/hematology 132, 17-26, 2018 | 13 | 2018 |
| HIV Nef enhances the expression of oncogenic c-MYC and activation-induced cytidine deaminase in Burkitt lymphoma cells, promoting genomic instability N Mdletshe, A Nel, K Shires, S Mowla Infectious Agents and Cancer 15, 1-10, 2020 | 11 | 2020 |
| Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia LA Du Pisani, K Shires Hematology/Oncology and Stem Cell Therapy 8 (3), 106-114, 2015 | 9 | 2015 |
| Efficiency of buccal DNA sampling device in the mortuary S Tredoux, S Mfolozi, K Shires Avens Publishing Group, 2015 | 8 | 2015 |
| FLT3 ITD detection: a closer look at the options: peer reviewed technical report K Shires, I Shankland, T Gerdener Medical Technology SA 25 (2), 39-46, 2011 | 6 | 2011 |
| Cancer/testis antigen expression panel incorporating MAGEC1 and BAGE2 predicts multiple myeloma disease stage and severity K Shires, A Teuchert, K Wienand, I Shankland, N Novitzky OMICS publishing group, 2016 | 5 | 2016 |
| Cytogenetically normal acute myeloid leukaemia at a single centre in South Africa N Jenkins, LA Blanshard, M Stone, E Verburgh, J Oosthuizen, K Shires Hematology/Oncology and Stem Cell Therapy 16 (4), 397-406, 2023 | 4 | 2023 |
| JAK2/STAT5 pathway mutation frequencies in South African BCR/ABL negative MPN patients KL Shires, AJ Rust, R Harryparsad, JA Coburn, RE Gopie Hematology/Oncology and Stem Cell Therapy 16 (3), 291-302, 2023 | 4 | 2023 |
| Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells K Shires, I Shankland, S Mowla, S Njikan, J Jaymacker Hematology/Oncology and Stem Cell Therapy 7 (1), 32-40, 2014 | 3 | 2014 |
| The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients K Shires, T Van Wyk, K Wienand Blood research 56 (3), 156-165, 2021 | 1 | 2021 |
| Novel multiplex RT-PCR assay to detect BCR/ABL mRNA variants K Shires, A Rust The Journal of Medical Laboratory Science and Technology of South Africa 2 …, 2020 | 1 | 2020 |
| Development of a multiplex assay to detect TERC and TERT mutations associated with immunosuppression therapy failure in Aplastic Anaemia patients. K Xulu, A Rust, K Shires International Journal of Laboratory Hematology 41 (2), 2019 | | 2019 |
| Abstract B18: MAGEC1 and BAGE2 mRNA expression can be used to monitor chemotherapy treatment responses in multiple myeloma patients and pre-empt clinical relapse K Shires, K Wienand Cancer Research 77 (22_Supplement), B18-B18, 2017 | | 2017 |
| MAGEC1 and BAGE2 mRNA expression can be used to monitor chemotherapy treatment responses in multiple myeloma patients and pre-empt clinical relapse K Shires, K Wienand CANCER RESEARCH 77 (22), 2017 | | 2017 |
| IMPLEMENTATION OF THE JAK2 V617F MUTATION ANALYSIS IN THE DIAGNOSIS OF SUSPECTED MYELOPROLIFERATIVE NEOPLASMS IN CAPE TOWN E Verburgh, E Poulet, K Shires, N Novitzky, C du Toit HAEMATOLOGICA 101, 813-813, 2016 | | 2016 |
| Journal of Hematology & Thromboembolic Diseases K Shires, A Teuchert, K Wienand, I Shankland, N Novitzky | | 2016 |
